Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

NBE Therapeutics (Switzerland) | Researchclopedia

Back to institutions

NBE Therapeutics (Switzerland)

Baselcompany

71

Works

4,808

Citations

36

h-index

Top Research Topics

Monoclonal and Polyclonal Antibodies Research CAR-T cell therapy research HER2/EGFR in Cancer Research

Top Researchers

Doriano Fabbro DecImmune Therapeutics (United States)

350 works29,586 citationsh-index: 89

Recent Research

LBS1:02 CD19-targeting chimeric antigen receptor (CAR) T-cell therapy, obecabtagene autoleucel (obe-cel), in severe refractory systemic lupus erythematosus (srSLE): initial results from phase I CARLYSLE study

Maria Leandro,Ruth Pepper,et al.

20260 citations

Chronic Lymphocytic Leukemia Research

Biochemical and Structural Characterization

Cancer Immunotherapy and Biomarkers

Chemical Synthesis and Analysis

Lymphoma Diagnosis and Treatment

Immunotherapy and Immune Responses

Single-cell and spatial transcriptomics

Computational Drug Discovery Methods

Genetics, Aging, and Longevity in Model Organisms

Thanos D. Halazonetis University of Geneva

184 works24,484 citationsh-index: 61

Roger R. Beerli

79 works7,900 citationsh-index: 35

David Colecchia DecImmune Therapeutics (United States)

25 works6,979 citationsh-index: 17

Ulrike Fiedler NBE Therapeutics (Switzerland)

102 works6,262 citationsh-index: 32

Richard Delarue NBE Therapeutics (Switzerland)

223 works6,233 citationsh-index: 37

VHH antibody loop guides design of a synthetic macrocyclic peptide that potently blocks influenza virus membrane fusion

Rameshwar U. Kadam,Jarek Juraszek,et al.

20251 citations

Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia

Hanny Al‐Samkari,Josefien Hessels,et al.

20253 citations

A degron-mimicking molecular glue drives CRBN homo-dimerization and degradation

Gerasimos Langousis,Pablo Gaínza,et al.

20253 citations

Preliminary results from a phase 1/1b first-in-human study of BGB-21447, a next-generation BCL2 inhibitor, in patients with B-cell non-Hodgkin lymphoma

Fei Li,Stephen Opat,et al.

20250 citations

Progression-free survival in patients with low health-related quality of life treated with zanubrutinib versus ibrutinib monotherapy: Post hoc analysis of the ALPINE trial

Loïc Ysebaert,Timothy W. Victor,et al.

20250 citations